Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
The Long Run with Luke Timmerman
Timmerman Report
The Science of Personality Podcast
Hogan Assessments
Real Science Exchange-Dairy
Balchem Animal Nutrition & Health
Τα podcasts του Newshub.gr
newshub.gr
TED-Ed
TED-Ed
Behavioral Health Today
Triad
StallSide Podcast
Rood & Riddle Veterinary Pharmacy, Bart Barber, Peter Morresey, Screeneye
Gresham College Lectures
Gresham College
muckrAIkers
Jacob Haimes and Igor Krawczuk
The Secret Teachings
Ryan Gable
Dark Mysteries — Unsolved Mysteries. Forgotten Secrets. Unanswered Questions.
Darkest Mysteries Online
Thrilling Threads - Conspiracy Theories, Strange Phenomena, True Crime, Unsolved Mysteries, etc!
Byte & Pieces
The IDEMS Podcast
IDEMS International
Ghost Wax
Far and Tall Tales
Bigfoot Society
Jeremiah Byron
Transmission
Ysabelle Swan
The Uptime Wind Energy Podcast
Allen Hall, Rosemary Barnes, Yolanda Padron & Matthew Stead
Dark Outdoors
darkoutdoors
PBS Space Time
PBS
Mr.希爾
Mr.希爾
uyfljlhjlkjgghlkjgjklgl
the master
שלושה שיודעים Three Who Know
כאן | Kan
Lydia Benecke präsentiert: WTF Talk - Wissenschaft trifft Freundschaft
Lydia Benecke, Festivalia GmbH
Short Wave
NPR
The Jordan Harbinger Show
Jordan Harbinger
De Psychologie van Succes Podcast
Albert Sonnevelt en Tonny Loorbach
The Constant: A History of Getting Things Wrong
Mark Chrisler
The Functional Breeding Podcast
The Functional Dog Collaborative
BirdNote Daily
BirdNote
Monsters Among Us
Derek Hayes | Audioboom Studios
Earthlings 2.0 Podcast
Lisa Ann Pinkerton
冷门知识 | 丰富你的知识储备
_要_有_光_
The Motivation Mindset with Risa Williams
Risa Williams
Nourish by Spinneys
Spinneys
Today's Creation Moment
Creation Moments
CRAMPED
Kate Helen Downey
ATTD: Advanced Technologies and Treatments for Diabetes
ATTD on UNLOK
Science
Timmerman Report
Heather Turner, CEO of New York-based LB Pharma, on developing a new schizophrenia drug designed to better cross the blood-brain barrier, be dosed once daily, and make it easier for patients to take long term.
Troy Wilson, CEO of San Diego-based Kura Oncology, on his career in biotech and developing targeted cancer drugs.
Sri Kosuri, co-founder and CEO of Emeryville, Calif.-based Octant Bio, on small molecules designed to correct protein misfolding and mistrafficking at the root of many diseases.
Becky Pferdehirt, CEO of Emeryville, CA-based Radial, the life sciences unit of Astera Institute, on reimagining biology to take advantage of advances in AI.
Jeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."
Alkermes CEO Richard Pops reflects on his 35-year career leading the company and its new opportunity in orexin biology for sleep disorders and more neurological conditions.
Marty Burke, a professor of chemistry at the University of Illinois and co-founder of Excelsior Sciences, on making small molecule synthesis more automated for AI.
Abbas Kazimi, CEO of Boston-based Nimbus Therapeutics, on computation and culture for drug discovery.
Viswa Colluru, founder and CEO of Boulder, Colo.-based Enveda, on drug discovery with a chemistry platform inspired by natural products.
Otello Stampacchia, founder and managing director of Omega Funds, on attempting to reform Europe's biotech investment climate.
Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery by Timmerman Report
Ron Renaud, CEO of Waltham, Mass.-based Kailera Therapeutics, on developing GLP-1 based medicines to help people lose weight and live healthier lives.
Kate Haviland, former CEO of Blueprint Medicines, on how the company transitioned to a precision immunology company and was acquired by Sanofi for $9.5 billion.
Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).
Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.
Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.
Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.
Eric Fischer, a professor at Dana-Farber Cancer Institute, on creating a new class medicines -- targeted protein degraders.
Bruce Levine, a CAR-T cell therapy researcher at the University of Pennsylvania, and Mags McCarthy, a country music star, discuss their new song about science and hope for cancer patients.
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.